BioDelivery Sciences International, Inc. (NASDAQ:BDSI)

CAPS Rating: 2 out of 5

A biopharmaceutical company that is utilizing its licensed, owned and proprietary patented drug delivery technologies to develop and commercialize, either on its own or in partnerships with third parties.

Recs

0
Player Avatar manirg (59.84) Submitted: 3/9/2014 10:28:55 PM : Outperform Start Price: $9.03 BDSI Score: +35.56

Undervalued. FDA approved drug and more coming. Proven delivery
system. A 5-10x potential.

Featured Broker Partners


Advertisement